You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 1, January 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Surgery, Other
 •Alert me on articles by topic

Hypertonic Saline Infusion for Pulmonary Injury Due to Ischemia-Reperfusion

Conor J. Shields, MB, AFRCSI; Desmond C. Winter, MD, FRCSI; Brian J. Manning, MB, AFRCSI; Jiang Huai Wang, PhD; William O. Kirwan, MCh, FRCSI; H. Paul Redmond, BSc, MCh, FRCSI

Arch Surg. 2003;138:9-14.

Hypothesis  Inhibition of neutrophil-endothelial cell interactions by hypertonic saline (HTS) may confer protection against organ injury in states of immunologic disarray. This study tested the hypothesis that infusion of HTS modulates the development of end-organ injury in a model of lower-torso ischemia-reperfusion injury.

Design  Ischemia-reperfusion injury was induced in 30 male Sprague-Dawley rats by infrarenal aortic cross-clamp for 30 minutes, followed by reperfusion for 2 hours. At 0 and 60 minutes of reperfusion, intravenous HTS (7.5% sodium chloride, 4 mL/kg) was administered to 6 rats each, and another 12 received either 4 or 30 mL/kg of isotonic sodium chloride solution. Six rats received HTS, 4 mL/kg, before ischemia. At 2 hours, we assessed liver function, pulmonary injury, neutrophil infiltration (myeloperoxidase activity), endothelial permeability (bronchoalveolar lavage and wet-dry weight ratios), and proinflammatory cytokine levels (tumor necrosis factor {alpha} and interleukin 6).

Results  Infusion with HTS before or after ischemia significantly reduced end-organ injury. Histopathologic pulmonary injury scores were markedly attenuated in the HTS group (5.82 ± 1.3) and the HTS pretreated group (4.91 ± 1.6) compared with the isotonic sodium chloride solution groups (8.54 ± 1.1) (P = .04). Pulmonary neutrophil sequestration (2.07 ± 0.23) and increased endothelial permeability (4.68 ± 0.44) were manifest in animals resuscitated with isotonic sodium chloride solution compared with HTS treatment (1.54 ± 0.19 [P = .04] and 2.06 ± 0.26 [P = .02]) and pretreatment (1.18 ± 0.12 [P = .04] and 1.25 ± 0.07 [P = .002]). In addition, a significant reduction in serum tumor necrosis factor {alpha} (P = .04) and interleukin 6 (P = .048) levels was observed, whereas HTS resuscitation attenuated the upsurge in aspartate transaminase (P = .03) and alanine transaminase levels (P = .047).

Conclusions  Resuscitation with HTS attenuates the pulmonary edema and tissue injury due to lower-torso ischemia-reperfusion and maintains a more benign immunologic profile.


From the Department of Academic Surgery, Cork University Hospital and National University of Ireland, Wilton.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effects of Hypertonic Resuscitation
Shields and Winter
Anesth. Analg. 2005;100:1859-1859.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.